Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index; none of the 74 sources its claims cite is checked for support yet.
Abstract
Introduction: Two different disease‐specific mutations in the BRI2 gene, situated on chromosome 13, have been identified as giving rise to familial British dementia (FBD) and familial Danish dementia (FDD). Each mutation results in extension of the open reading frame generating the disease‐specific precursor proteins which are cleaved by furin‐like proteolysis releasing the amyloidogenic C‐terminal peptides ABri and ADan in FBD and FDD, respectively. Material and methods: To understand the mechanism of the formation of amyloid lesions in FBD, we studied the origin of the precursor proteins and furin in the human brain. We used control brains, cases of sporadic Alzheimer's disease (AD), variant AD with cotton wool plaques and FBD to study BRI2 mRNA expression using in situ hybridization. Furin and BRI2 protein expression was investigated using Western blotting and immunohistochemistry. Results: BRI2 mRNA and BRI2 protein are widely expressed primarily by neurones and glia and are deposited in the amyloid lesions in FBD. They were, however, not expressed by cerebrovascular components. Furin expression showed a similar pattern except that it was also present in cerebrovascular smooth muscle cells. Conclusions: These findings suggest that neurones and glia and are a major source of BRI2 protein and that in FBD, the mutated precursor protein may undergo furin cleavage within neurones to produce the amyloid peptide ABri. The failure to demonstrate BRI2 in blood vessels under the conditions tested suggests that vascular amyloid peptide production does not contribute significantly to cerebral amyloid angiopathy (CAA) in FBD and FDD, lending indirect support to the drainage hypothesis of CAA.
Overview
CoChat Summary
TL;DR
BRI2 mRNA and protein are widely expressed by neurones and glia throughout normal human brain, with furin showing a similar distribution except in cerebrovascular smooth muscle cells. In familial British dementia, BRI2 mRNA, BRI2 and furin are present in vascular and parenchymal amyloid lesions but not preamyloid lesions, suggesting local neuronal/glial production and processing rather than a major vascular origin of ABri.
Key findings
- In normal human brain, BRI2 mRNA and BRI2 protein were widely expressed primarily by neurones and glia; vascular smooth muscle and endothelial cells showed no identifiable BRI2 mRNA or BRI2, while furin was present in cerebrovascular smooth muscle cells.
- In FBD, parenchymal amyloid lesions contained BRI2 mRNA and BRI2 protein, and vascular amyloid deposits were associated with BRI2 mRNA and BRI2; preamyloid lesions were unstained. Furin was also found in FBD parenchymal and amyloid-laden vascular lesions.
- In sporadic AD and variant AD with cotton wool plaques, BRI2 mRNA was found in amyloid plaques and amyloid-laden vessels, but no lesional deposition of BRI2 or furin was found in amyloid or preamyloid lesions.
- Western and Northern analyses identified BRI2 mRNA at 2.0 kb, BRI2 protein at 39–41 kDa, and furin at 90 and 96 kDa.
Methods
- Post-mortem flash-frozen brain tissue from four normal controls, one FBD case, four AD cases, and one variant AD case with cotton wool plaques; regions included frontal cortex, basal ganglia, hippocampus, cerebellum, and others depending on availability.
- BRI2 mRNA expression was studied by in situ hybridization using three DIG-labelled oligonucleotide probes; BRI2 and furin protein expression was studied by Western blotting and immunohistochemistry, with double immunofluorescence using NeuN, GFAP, CD68, CR3/43 and Thioflavine-S.
- Findings were compared descriptively across control, FBD, and AD cases; no quantitative statistical analysis is reported.
Limitations
- The paper states that a small amount of BRI mRNA and BRI2 below the threshold of the methods used could be expressed by vascular components, as indicated by cell culture experiments; it also notes that Ab340 may recognize both full-length BRI2 and the N-terminal fragment generated by furin-like processing, so these fragments may contribute to positive immunohistochemical results.
- Evident from the text: the sample is very small, especially one FBD case and one variant AD case, limiting generalizability.
- Evident from the text: the biological function of BRI2 remains unknown, and the study relies on descriptive staining patterns without quantitative measures.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 0 Not valid · 44 Not checked · 75 Own results and interpretations
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Furin expression showed a similar pattern except that it was also present in cerebrovascular smooth muscle cells.”
§ Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease > Abstract
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These studies showed that both proteins are diffusely expressed by CD68positive microglia (Figure 5, rows C and F).”
§ Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease > Distribution of BRI2 mRNA, BRI2 and furin in FBD and AD
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Blood vessels were consistently unstained by Ab340.”
§ Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease > Distribution and staining pattern of BRI2 in normal human brain
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neurones of all sizes and in all cortical, subcortical and cerebellar regions examined showed strongly positive staining for furin with a punctate cytoplasmic distribution extending into the apical dendrite of pyramidal cells (Figure 3C).”
§ Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease > Distribution and staining pattern of furin in normal human brain
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In all areas of the brain, vascular smooth muscle cells were found to contain furin (Figure 3D).”
§ Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease > Distribution and staining pattern of furin in normal human brain
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
72 more claims
Create a free account to see all 119 claims and every source verdict.
- It may state two separate claims as one. 26
- Probably not a substantial claim. 23
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease > BRI2 mRNA in situ hybridization
“Three oligonucleotide probes complementary to residues 28-68, 609-648 and 802-836 of BRI2 cDNA (Table 2) were labelled”
§ Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease > Distribution of BRI2 mRNA assessed by in situ hybridization in normal human brain
“the figures have been illustrated using the sequence complementary to residues 28-66 of BRI2 cDNA”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease > Tissue
“For Western blot analysis, tissue from the cerebellum of four of the control cases and frontal lobe from the FBD case was used.”
§ Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: its relevance to the pathogenesis of disease > Western blot analysis
“The monoclonal antibody Ab340 was characterized by immunoblotting of cerebellar tissue from four controls and one FBD case”
Citations
Cites
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
Chomczynski, P., & Sacchi, N. (1987) · Analytical Biochemistry · doi:10.1016/0003-2697(87)90021-2 · Cited by 46,426
The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system
Shu, S., Ju, G., & Fan, L. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90346-1 · Cited by 1,227
Handbook of Clinical Neurology: Disorders of Speech, Perception, and Symbolic Behavior, Vol. 4
BENTON, A. L. (1970) · Neurology · doi:10.1212/wnl.20.12.1220 · Cited by 1,101
Weller, R. O., Massey, A., Newman, T. A., Hutchings, M., Kuo, Y.-M., & Roher, A. E. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65616-7 · Cited by 679
Cerebral amyloid angiopathy without and with cerebral hemorrhages: A comparative histological study
Vonsattel, J. P. G., Myers, R. H., Tessa Hedley‐Whyte, E., Ropper, A. H., Bird, E. D., & Richardson, E. P. (1991) · Annals of Neurology · doi:10.1002/ana.410300503 · Cited by 662
Adult neurogenesis and neural stem cells of the central nervous system in mammals
Taupin, P., & Gage, F. H. (2002) · Journal of Neuroscience Research · doi:10.1002/jnr.10378 · Cited by 527
A stop-codon mutation in the BRI gene associated with familial British dementia
Vidal, R., Frangione, B., Rostagno, A., Mead, S., Révész, T., Plant, G., & Ghiso, J. (1999) · Nature · doi:10.1038/21637 · Cited by 466
Self-citationBenjannet, S., Elagoz, A., Wickham, L., Mamarbachi, M., Munzer, J. S., Basak, A., Lazure, C., Cromlish, J. A., Sisodia, S., Checler, F., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009899200 · Cited by 301
Vidal, R., Révész, T., Rostagno, A., Kim, E., Holton, J. L., Bek, T., Bojsen-Møller, M., Braendgaard, H., Plant, G., Ghiso, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080076097 · Cited by 300
Self-citationCerebral Amyloid Angiopathies: A Pathologic, Biochemical, and Genetic View
Revesz, T., Ghiso, J., Lashley, T., Plant, G., Rostagno, A., Frangione, B., & Holton, J. L. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.9.885 · Cited by 288
Self-citationA Furin-like Convertase Mediates Propeptide Cleavage of BACE, the Alzheimer's β-Secretase
Bennett, B. D., Denis, P., Haniu, M., Teplow, D. B., Kahn, S., Louis, J.-C., Citron, M., & Vassar, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005339200 · Cited by 273
Hashimoto, T. (2002) · The EMBO Journal · doi:10.1093/emboj/21.7.1524 · Cited by 227
Olichney, J. M., Hansen, L. A., Galasko, D., Saitoh, T., Hofstetter, C. R., Katzman, R., & Thal, L. J. (1996) · Neurology · doi:10.1212/wnl.47.1.190 · Cited by 216
Sporadic and Familial Cerebral Amyloid Angiopathies
Revesz, T., Holton, J. L., Lashley, T., Plant, G., Rostagno, A., Ghiso, J., & Frangione, B. (2002) · Brain Pathology · doi:10.1111/j.1750-3639.2002.tb00449.x · Cited by 199
Self-citationMechanism of Cerebral β-Amyloid Angiopathy: Murine and Cellular Models
Herzig, M. C., Nostrand, W. E., & Jucker, M. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.tb00560.x · Cited by 169
Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia
Kim, S.-H., Wang, R., Gordon, D. J., Bass, J., Steiner, D. F., Lynn, D. G., Thinakaran, G., Meredith, S. C., & Sisodia, S. S. (1999) · Nature Neuroscience · doi:10.1038/14783 · Cited by 154
Processing of β-Secretase by Furin and Other Members of the Proprotein Convertase Family
Creemers, J. W. M., Ines Dominguez, D., Plets, E., Serneels, L., Taylor, N. A., Multhaup, G., Craessaerts, K., Annaert, W., & De Strooper, B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006947200 · Cited by 147
Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca2+ stabilization
Chen, C.-D., Huff, M. E., Matteson, J., Page, L. J., Phillips, R., Kelly, J. W., & Balch, W. E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.22.6277 · Cited by 147
Matsuda, S., Giliberto, L., Matsuda, Y., Davies, P., McGowan, E., Pickford, F., Ghiso, J., Frangione, B., & D'Adamio, L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500217200 · Cited by 141
Self-citationAmyloid accomplices and enforcers
Alexandrescu, A. T. (2004) · Protein Science · doi:10.1110/ps.04887005 · Cited by 138
Houlden, H., Baker, M., McGowan, E., Lewis, P., Hutton, M., Crook, R., Wood, N. W., Kumar-Singh, S., Geddes, J., Swash, M., et al. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200011)48:5<806::aid-ana18>3.0.co;2-f · Cited by 135
Self-citationHolton, J. L., Lashley, T., Ghiso, J., Braendgaard, H., Vidal, R., Guerin, C. J., Gibb, G., Hanger, D. P., Rostagno, A., Anderton, B. H., et al. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.3.254 · Cited by 133
Self-citationFAMILIAL CEREBRAL AMYLOID ANGIOPATHY WITH NONNEURITIC AMYLOID PLAQUE FORMATION
PLANT, G. T., RÉVÉSZ, T., BARNARD, R. O., HARDING, A. E., & GAUTIER-SMITH, P. C. (1990) · Brain · doi:10.1093/brain/113.3.721 · Cited by 132
Self-citationFRACKOWIAK, J., ZOLTOWSKA, A., & WISNIEWSKI, H. M. (1994) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199411000-00011 · Cited by 128
Lopez‐Perez, E., Zhang, Y., Frank, S. J., Creemers, J., Seidah, N., & Checler, F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00180.x · Cited by 126
Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques
Ginsberg, S. D., Crino, P. B., Hemby, S. E., Weingarten, J. A., Lee, V. M.-Y., Eberwine, J. H., & Trojanowski, J. Q. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2<174::aid-ana7>3.0.co;2-e · Cited by 126
BRI2 Interacts with Amyloid Precursor Protein (APP) and Regulates Amyloid β (Aβ) Production
Fotinopoulou, A., Tsachaki, M., Vlavaki, M., Poulopoulos, A., Rostagno, A., Frangione, B., Ghiso, J., & Efthimiopoulos, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500231200 · Cited by 114
Self-citationHolton, J. L., Ghiso, J., Lashley, T., Rostagno, A., Guerin, C. J., Gibb, G., Houlden, H., Ayling, H., Martinian, L., Anderton, B. H., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63993-4 · Cited by 114
Self-citationFamilial British dementia with amyloid angiopathy
Mead, S., James-Galton, M., Revesz, T., Doshi, R. B., Harwood, G., Pan, E. L., Ghiso, J., Frangione, B., & Plant, G. (2000) · Brain · doi:10.1093/brain/123.5.975 · Cited by 112
Self-citationIsolation of Markers for Chondro-osteogenic Differentiation Using cDNA Library Subtraction
Deleersnijder, W., Hong, G., Cortvrindt, R., Poirier, C., Tylzanowski, P., Pittois, K., Van Marck, E., & Merregaert, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19475 · Cited by 106
WORSTER-DROUGHT, C., GREENFIELD, J. G., & McMENEMEY, W. H. (1940) · Brain · doi:10.1093/brain/63.3.237 · Cited by 94
Familial Presenile Dementia with Spastic Paralysis
Worster-Drought, C., Hill, T. R., & McMenemey, W. H. (1933) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.s1-14.53.27 · Cited by 94
A FORM OF FAMILIAL PRESENILE DEMENTIA WITH SPASTIC PARALYSIS
WORSTER-DROUGHT, C., GREENFIELD, J. G., & MCMENEMEY, W. H. (1944) · Brain · doi:10.1093/brain/67.1.38 · Cited by 82
Systemic Amyloid Deposits in Familial British Dementia
Ghiso, J. A., Holton, J., Miravalle, L., Calero, M., Lashley, T., Vidal, R., Houlden, H., Wood, N., Neubert, T. A., Rostagno, A., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105956200 · Cited by 80
Self-citationComplement Activation in Chromosome 13 Dementias
Rostagno, A., Revesz, T., Lashley, T., Tomidokoro, Y., Magnotti, L., Braendgaard, H., Plant, G., Bojsen-Møller, M., Holton, J., Frangione, B., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206448200 · Cited by 64
Self-citationRostagno, A. A., Tomidokoro, Y., Lashley, T., Ng, D., Plant, G. T., Holton, J. L., Frangione, B., Révész, T., & Ghiso, J. A. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5092-5 · Cited by 64
Self-citationProteolytic Processing of Familial British Dementia-associated BRI Variants
Kim, S.-H., Creemers, J. W. M., Chu, S., Thinakaran, G., & Sisodia, S. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108739200 · Cited by 63
Akiyama, H., Kondo, H., Arai, T., Ikeda, K., Kato, M., Iseki, E., Schwab, C., & McGeer, P. L. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0783-1 · Cited by 63
Révész, T., Holton, J. L., Doshi, B., Anderton, B. H., Scaravilli, F., & Plant, G. T. (1999) · Acta Neuropathologica · doi:10.1007/s004010050970 · Cited by 62
Self-citationAmyloid β precursor protein-mRNA is expressed throughout cerebral vessel walls
Natté, R., de Boer, W. I., Maat–Schieman, M. L. C., Baelde, H. J., Vinters, H. V., Roos, R. A. C., & van Duinen, S. G. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01361-x · Cited by 56
Axonal transport of British and Danish amyloid peptides via secretory vesicles
Choi, S., Vidal, R., Frangione, B., & Levy, E. (2004) · The FASEB Journal · doi:10.1096/fj.03-0730fje · Cited by 55
Self-citationCongophilic angiopathy of the brain: a clinical and pathological report on two siblings.
Griffiths, R. A., Mortimer, T. F., Oppenheimer, D. R., & Spalding, J. M. (1982) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.45.5.396 · Cited by 52
Pittois, K., Deleersnijder, W., & Merregaert, J. (1998) · Gene · doi:10.1016/s0378-1119(98)00354-0 · Cited by 48
CATARACT, DEAFNESS, CEREBELLAR ATAXIA, PSYCHOSIS AND DEMENTIA-A NEW SYNDROME
Strömgren, E., Dalby, A., Dalby, M. A., & Ranheim, B. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1970.tb02219.x · Cited by 46
Genetic Alterations of the BRI2 gene: Familial British and Danish Dementias
J, G., A, R., Y, T., T, L., M, B.-M., H, B., G, P., J, H., R, L., T, R., et al. (2006) · Brain Pathology · doi:10.1111/j.1750-3639.2006.tb00563.x · Cited by 44
Self-citationβAPP and Furin mRNA Concentrates in Immature Senile Plaques in the Brain of Alzheimer Patients
Marcinkiewicz, M. M. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.9.915 · Cited by 39
Upregulation of stress response mRNAs in COS-7 cells exposed to cadmium
Lee, M. J., Nishio, H., Ayaki, H., Yamamoto, M., & Sumino, K. (2002) · Toxicology · doi:10.1016/s0300-483x(02)00045-8 · Cited by 34
Lashley, T., Holton, J. L., Verbeek, M. M., Rostagno, A., Bojsen‐Møller, M., David, G., Van Horssen, J., Braendgaard, H., Plant, G., Frangione, B., et al. (2006) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2006.00747.x · Cited by 33
Self-citationGenomic organization and chromosomal localization of the Itm2a gene
Pittois, K., Wauters, J., Bossuyt, P., Deleersnijder, W., & Merregaert, J. (1999) · Mammalian Genome · doi:10.1007/s003359900942 · Cited by 32
Familial cerebellar ataxia with cerebrovascular amyloid
Love, S., & Duchen, L. (1982) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.45.3.271 · Cited by 29
causing amyloid angiopathy and brain hemorrhage ‐ clinical genetics in Iceland
Jensson, Ó., Pálsdóttir, Á., Thorsteinsson, L., & Árnason, A. (1989) · Clinical Genetics · doi:10.1111/j.1399-0004.1989.tb03215.x · Cited by 24
Pickford, F., Onstead, L., Camacho-Prihar, C., Hardy, J., & McGowan, E. M. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01356-3 · Cited by 16
Familial British dementia: colocalization of furin and ABri amyloid
Schwab, C., Hosokawa, M., Akiyama, H., & McGeer, P. L. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0735-9 · Cited by 14
Research works printed but not linked: 1
- Stromgren E, 1981, Handbook of Clinical Neurology, 150
Cited by
Weller, R. O., Boche, D., & Nicoll, J. A. R. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0498-z · Cited by 297
“They include cystatin, transthyretin, gesolin, prion protein [67] and the amyloid deposited in the vessel walls in the British and Danish types of dementia [45].”
BackgroundGenetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies
Revesz, T., Holton, J. L., Lashley, T., Plant, G., Frangione, B., Rostagno, A., & Ghiso, J. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0501-8 · Cited by 294
Self-citationMilardi, D., Gazit, E., Radford, S. E., Xu, Y., Gallardo, R. U., Caflisch, A., Westermark, G. T., Westermark, P., Rosa, C. L., & Ramamoorthy, A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00981 · Cited by 196
Cerebral amyloid angiopathy in the aetiology and immunotherapy of Alzheimer disease
Weller, R. O., Preston, S. D., Subash, M., & Carare, R. O. (2009) · Alzheimer's Research & Therapy · doi:10.1186/alzrt6 · Cited by 144
Cognitive impairment of vascular origin: Neuropathology of cognitive impairment of vascular origin
Ferrer, I. (2010) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2010.08.039 · Cited by 88
Metadata
- Authors
- Lashley, T., Revesz, T., Plant, G., Bandopadhyay, R., Lees, A. J., Frangione, B., Wood, N. W., De Silva, R., Ghiso, J., Rostagno, A., & Holton, J. L.
- Affiliations
- National Hospital for Neurology and Neurosurgery (GB)
- New York University (US)
- UCL Queen Square Institute of Neurology (GB)
- ORCID
- Venue
- Neuropathology and Applied Neurobiology
- Publisher
- Wiley
- Published
- 2008-09-29
- Volume
- 34
- Issue
- 5
- Pages
- 492-505
- ISSN
- 0305-1846 (ISSN-L)
- 1365-2990
- PMC
- PMC2795351
- OpenAlex
- W2076227489
- Cited by
- 31
- References
- 53
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 3 · 2016: 1 · 2015: 2 · 2014: 4 · 2013: 1 · 2012: 1
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neuropathology and Applied Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- American Heart Association
- Alzheimer's Research Trust
- National Institutes of Health
- U.S. Public Health Service (AGO5891)
- Medical Research Council (G0501560)
- National Institute on Aging (P01AG010491, R37AG005891, R01AG010941)
- National Institute of Neurological Disorders and Stroke (R01NS051715)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Intracerebral and Subarachnoid Hemorrhage Research
- Keywords
- familial British dementia, familial Danish dementia, furin, amyloid precursor protein, amyloid plaques, neuronal expression, glial expression, cerebrovascular smooth muscle cells, cerebral amyloid angiopathy, sporadic Alzheimer's disease
- MeSH terms
- Adult, Aged, Aged, 80 and over, Alzheimer Disease, Brain, Dementia, Female, Fluorescent Antibody Technique, Humans, Immunohistochemistry, Male, Membrane Glycoproteins, Membrane Proteins, Middle Aged, Mutation, Neuroglia, Neurons, RNA, Messenger, Blotting, Northern, Blotting, Western, Polymerase Chain Reaction, In Situ Hybridization, Furin, Adaptor Proteins, Signal Transducing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-21, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-21 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.